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S u m m a r y  
 
A i m  o f  s t u d y .  The assessment of nutritional status 
with a special attention towards overweight by 
anthropometric measurements and biochemical parameters of 
lipids in children with cancer. 
M a t e r i a l  a n d  m e t h o d s .  In a retrospective 
group data of 122 patients’ treatment history were analyzed. 
The patients were treated in our hospital in previous years 
and their weight and height were studied. In a prospective 
group 62 newly diagnosed children with cancer were 
examined. The additional anthropometric measurements were 
included in the research like skinfolds thickness and middle 
arm circumference and biochemical lipids date were taken. 
The data were analyzed three times: at the diagnosis, during 
the oncological treatment and after the intensive 
chemotherapy.   
R e s u l t s .  In a retrospective group, after the 
oncological treatment the number of children with 
overweight increased: M/W>90 ile 6.6%, BMI >90 ile 6.6%, 
%IBW above 110% 25.5%, Cole’a index above 110% 21.3% 
, whereas the number of children with height > 90 ile 
decreased to 6.6%. At the beginning, in a prospective group 
the number of children with overweight was three times 
higher-11.3%. 26.2% patients had abnormal level of 
triglicerydes at diagnosis and 30.4% after treatment. Above 
50% of patients had abnormal level of HDL cholesterol 
during the whole treatment.  
C o n c l u s i o n s .  Children with cancer belong to the 
group of risk for obesity and hyperlipidemia during the 
oncological treatment and it may impact on treatment and 
outcomes and also have serious medical consequence to the 
health state in future.  
 
 
S t r e s z c z e n i e  
 
Głównym celem prowadzonych badań była ocena stanu 
odżywienia ze szczególnym uwzględnieniem parametrów 
antropometrycznych oraz stężenia lipidów u dzieci leczonych 
z powodu choroby nowotworowej 
M a t e r i a ł  i  m e t o d y .  Ocenie retrospektywnej 
poddano dane uzyskane podczas hospitalizacji 122 pacjentów 
leczonych w Klinice Pediatrii Hematologii i Onkologii 
Collegium Medicum Uniwersytetu Mikołaja Kopernika  
w Toruniu. Badanie poszerzono o ocenę prospektywną  
62 dzieci z rozpoznaniem choroby nowotworowej. Badania 
antropometryczne obejmowały pomiar fału skórnego oraz 
obwód ramienia, a ponadto przeprowadzono ocenę para-
metrów lipidowych w momencie postawienia diagnozy,  
w trakcie leczenia onkologicznego oraz po zakończeniu 
intensywnej chemioterapii. 
W y n i k i .  W grupie poddanej ocenie retrospektywnej, 
po leczeniu onkologicznym liczba dzieci z nadwagą wzrosła: 
M/W> 90 percentyla – 6,6%, BMI> 90% percentyla – 6,6%, 
powyżej 110% ICC – 25,5%, współczynnik Cole'a powyżej 
110% – 21,3%, podczas gdy liczba dzieci ze wzrostem > 90 
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percentyla zmniejszyła się do 6,6%. Na początku leczenia, w 
grupie ocenianej prospektywnie liczba dzieci z nadwagą była 
trzy razy wyższa i wyniosła 11,3%. U 26,2% pacjentów 
obserwowano nieprawidłowe stężenie trójglicerydów na 
początku badania i u 30,4% po leczeniu. Ponad 50% 
pacjentów miało nieprawidłowe stężenia cholesterolu HDL 
podczas całego leczenia. 
W n i o s k i .  Dzieci leczone z powodu choroby nowo-
tworowej nalezą do grupy podwyższonego ryzyka otyłości  
i hiperlipemii w czasie leczenia onkologicznego, co może 
wpływać na leczenie i rokowanie nie tylko krótkoterminowe, 
ale także odległe. 
 
Key words: cancer in children, obesity, hyperlipidemia  
Słowa kluczowe: choroba nowotworowa u dzieci, otyłość, hiperlipidemia 
 
Abbreviations  
MAC – middle arm circumference 
TSFT – triceps skinfold thickness 
SSFT – scapular skinfold thickness 




The disorder of nutritional status, usually in the 
form of malnutrition, is often observed among in 
pediatric oncological patients. In the developed 
countries there is also a growing number of overweight 
patients within this group. The published reports show 
the problem of obesity after oncological treatment, 
especially among children with acute lymphoblastic 
leukemia. There are more and more reports on the 
negative impact of obesity in children on the length 
and quality of life among long-term pediatric cancer 
survivors. Also the problem of bioavailability and 
distribution of chemotherapy is reported within this 
group of patients, which may affect the effectiveness of 
the treatment [1-3].There are also reports about the 
connection between the atherosclerotic lipids disorders 
and diabetes or cardiovascular diseases [3-7]. The 
mechanism of growing lipids disorder is multifactorial 
with possible unfavorable impact of cancer disease and 
particular applied treatment. 
Measuring the thickness of skinfolds thickness is a 
simple test helping to estimate the amount of fat tissue. 
The subcutaneous tissue is the first energetic reserve 
for organisms in the state of underfeeding or the 
growing loss. The local changes reflect the 
constitutional status, because more than a half of the 
fat is located in the subcutaneous tissue. 
 
MATERIALS AND METHODS 
 
Two groups of patients took part in the study. In the 
retrospective group (A) there were 122 patients at the 
age of 0-18, undergoing clinical oncological treatment 
in 2002-2008. There was the largest group of patients 
with acute leukemia (56 children), mostly with acute 
lymphoblastic leukemia, then with solid tumors  
(34 children) and treated due to lymphoma (32 
children).  
In the prospective group (B) there were 62 children 
at the age of 0-18 with newly diagnosed cancer, 
undergoing clinical treatment in 2008-2010. In the 
largest group there were patients with solid tumors (25 
children), then patients with acute leukemia (23 
children), in majority with acute lymphoblastic 
leukemia and 14 children undergoing treatment due to 
lymphoma. The assessment of the nutrition status was 
done 3 times: at diagnosis, half way of treatment and 
after the treatment was finished. In the retrospective 
group (A) body weight and height were measured, and 
such indices as BMI, Cole’s, % IBW were calculated 
using the following formula: BMI as the weight in 
kilograms to height in squared meters, % IBW as 
percentage of the ideal weight, Cole’s index as quotient 
of current and standard body mass index. In the 
prospective group (B) additional anthropometric 
measurements such as triceps, scapular and abdominal 
skinfolds thickness and the middle arm circumference 
were included. The biochemical lipids data were also 
taken: total cholesterol, HDL and LDL fractions and 
triglycerides.  
The data were analyzed in terms of reference 
growth charts of Polish children population.  
The Bioethics Committee at Collegium Medicum 
in Bydgoszcz of Nicolaus Copernicus University in 
Torun provided consent for conducting this experiment 
(KB/412/2008). 
The results over 90th percentile for anthropometric 
measurements and 110% in %IBW and Cole’s index 
were considered as abnormal and treated as 
overweight. 
The statistical analysis was done with statistical 
computer programme Statistica 9.1 of StartSoft 
company. The analysis of the correlation of qualitative 
variables was done with the help of test X2. P<0.05 
was assumed as statistically important. 





In group A, at diagnosis, most of the parameters 
showed up to 10% of children above normal range, so 
more than 90 percentiles or 110 % for the IBW index 
and Cole’s one. During the intensive treatment most of 
those indices showed the decrease in the number of 
children, and after the therapy all the indices, except 
height index, showed more percent of children than at 
diagnosis (table I). 
In group B, 10-20 % of children, at diagnosis, 
showed indices, based on the weight and height, above 
90 percentiles or more than 110% of the normal range, 
which indicated overweight. The percentage of 
children with weight over 90 percentiles at diagnosis 
was almost three times higher in group B than in group 
A. The percentage of children with weight and height 
more than 90 percentiles after treatment was smaller 
than at diagnosis.  
 
Table I. The number of patients N(%) with parameters and 
anthropometric indices over 90 percentiles or more 
than 110% of normal range for IBW and Cole’s 
index in group A - retrospective study group of 122 























































































































The lipid parameters and additional anthropometric 
measurements in the prospective study group B. 
The abnormal concentration of cholesterol HDL 
below 40 mg/dl was observed at 67% of children, 
higher level of triglycerides over 150 mg% in 26% of 
children – in both cases with the prevalence in patients 
with leukemia. In 13% percent of children higher level 
of cholesterol LDL 130mg% was detected, and 14% of 
patients had the higher level of total cholesterol 
>200mg%. Lipid disorders were observed at similar 
level also after the intensive treatment. It was a bit 
lower in children with higher level of total cholesterol 
and LDL fraction (table II).  
Additional measurements of skinfolds thickness 
increased up to 30% the number of children, who had 
these parameters over 90 percentiles at diagnosis.  The 
number of children with skinfolds thickness over 90 
percentiles increased during and after treatment. 
The evaluation of the relation between 
mathematical indices based on height and weight 
measurements and anthropometric parameters that 
were taken at the same time showed that there was a 
statistically important correlation in every case 
between %IBW and Cole’s index and anthropometric 
parameters, and between BMI index and the middle 





Since the 80s there have been lots of reports 
concerning overweight and obesity among children 
after oncological treatment, especially in acute 
lymphoblastic leukemia. The number of survivors with 
overweight ranges from 11 to 57% , which depends on 
the definition of overweight taken into account and 
also on the time of measurement [1, 2]. 
In our own study in the retrospective group there 
were 4.1% of overweight 
children at diagnosis, and not 
more than 6.5 % in prospective 
assessment. After intensive 
chemotherapy weight/height 
index more than 90 percentile in 
the retrospective group was still 
low – 6.6%, and in prospective 
group it was 12.9%.  
Comparing the results of 
both examinations we observe 
that the number of overweight 
Table II. The number of patients N(%) with lipid disorders and additional 
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children was higher in 2008-2010 than in 2002-2008, 
but still lower than data based on research done on the 
population of healthy Polish children and teenagers 1-
18 years old in 2000 by the Institute of Food and 
Feeding in which weight/height index  was 24.4% [8, 
9, 10]. 
BMI index also indicated less frequent overweight 
in oncological patients in comparison to the population 
of healthy children. In the study of frequency of 
occurrence of overweight and obesity on the basis of 
Institute of Mother and Child’s BMI charts, published 
in 2002, in the group of children at the age of 7-9, the 
occurrence of overweight was reported among 20.9% 
of children. In our own research BMI over 90 
percentiles at diagnosis occurred in 4.1% of children in 
the retrospective group and 12.9% in the prospective 
one. The analysis of this index of nutrition status also 
shows the increase in number of overweight children in 
later study [10]. 
The anthropometric measurement of skinfolds 
thickness indicated more patients with outcomes over 
90 percentiles than parameters based on the muscles 
component of body at every stage of treatment, which 
is coherent to the previous studies in the 80s and which 
confirm the observation that reserves of fat tissue 
rebuild faster than proteins [11]. 
Less children with height index over 90 percentiles 
during the following assessment provides the height 
decline during the chronic disease and its treatment. 
In our own study we observed a surprisingly large 
group of children with lower level of HDL fraction and 
higher level of triglycerides. These abnormal results 
appeared also at the examination at the end of the 
treatment with similar frequency. Similar lipids 
disorders occurred in study done in pediatric oncology 
patients in the 80s [11]. Twenty years later, in study 
published in 2008 and done among a group of 25 
children with acute lymphoblastic leukemia also 
indicated the lower level of cholesterol HDL and 
higher level of triglycerides before the treatment in 
comparison to the population of healthy children. No 
correlation between the concentration of lipids and 
BMI was found [12]. In our own study, the 
atherosclerotic lipids disorder did not coexist with BMI 
over 90 percentiles in most cases. Potentially 
atherosclerotic lipids profile in a quite big group of 
children discovered at diagnosis confirms the 
correlation between the lipids disorder and cancer 
disease, especially they did not meet the criteria of 
congenital hyperlipidemia. Results of studies suggest 
starting the pharmacological treatment in congenital 
hyperlipidemia to reduce the risk of future cardio-
vascular events [7]. In our population of patients 
abnormal lipid profile was secondary, thus 
pharmacological treatment was not started. Moreover, 
statin treatment may be responsible for increased risk 
of chronic diseases such as diabetes [13]. Tan SY et al. 
concluded that the prevalence of being overweight and 
obesity in children with acute leukemia was higher 
despite lower energy intake compared to controls. 
Studies assessing physical activity, the complex 
interaction and the effects of treatment drugs are 
warranted to better manage malnutrition among 
pediatric patients [14]. Esbenshade AJ et al. in a 
prospective cohort of 34 pediatric acute lymphoblastic 
leukemia (ALL) patients, followed over the first 12 
months of ALL maintenance, evaluated changes in 
body mass index, blood pressure, fasting insulin and 
glucose, lipids, Homeostatic Metabolic Assessment 
(HOMA), leptin, and adiponectin. Author found that in 
these patients over the first year of ALL maintenance 
therapy demonstrated that components of the metabolic 
syndrome significantly worsen over time. Preventive 
interventions limiting increases in BMI and insulin 
resistance during maintenance therapy should be 
targeted during this time period to avoid long-term 
morbidity associated with the metabolic syndrome in 
long-term survivors [15]. Al-Tawil MM et al. 
described the studies associating chronic hepatitis C 
virus (HCV) infection with lipid profile and hepatic 
steatosis in leukemia or lymphoma cured children. 
Authors found that serum lipids were low or normal 
but unfortunately hepatic steatosis was found in a 
significant proportion of patients and was associated 
with a poor response to antiviral treatment [16]. 
The existence of these disorders after the intensive 
oncological treatment may indicate the negative effect 
of oncological treatment which may intensify and 
consolidate the abnormal lipids profile. Children with 
acute lymphoblastic leukemia administrated 
glicocortycosteroids and L-Asparaginase, with known 
negative impact on lipid parameters are in the group of 
increased risk of these disorders.  Reports on potential 
correlation between hypertriglycerides and 
thromboembolic complications and pancreatitis require 
a specially monitoring lipids disorder in this group of 
patients during the treatment [12]. 
 





The growing problem of obesity in healthy children 
in the recent decades concerns also the population of 
oncological children. They require a special attention 
and monitoring for negative impact on the 
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